Whilst respiratory infections and diseases have already been outlined as contraindications for HBOT, the case of SARS-CoV-two is an exception. Presently, the potential use of HBOT during the COVID-19 has become specially regarded, exposing leads to many controlled medical trials. Moreover, the usage of this treatment in various types of malignancie